What is Moon Surgical?
Moon Surgical is a pioneering force in the medical technology landscape, specifically focusing on the development of the Maestro System. This AI-powered surgical platform is engineered to enhance the efficiency and sustainability of modern operating rooms. By providing surgeons with actionable data through its Maestro Insights software, the company addresses the critical need for precision and digital integration in complex surgical procedures. Moon Surgical operates at the intersection of robotics and healthcare, aiming to empower institutions with scalable, innovative solutions that improve patient outcomes and streamline surgical workflows globally.
How much funding has Moon Surgical raised?
Moon Surgical has raised a total of $86.7M across 2 funding rounds:
Series A
$31.3M
Other Financing Round
$55.4M
Series A (2022): $31.3M with participation from Sofinnova Partners, Johnson & Johnson Innovation, Cathay Health, and GT Healthcare Capital & Partners
Other Financing Round (2023): $55.4M led by NVentures and Sofinnova Partners
Key Investors in Moon Surgical
Sofinnova Partners
A leading European venture capital firm in life sciences, specializing in healthcare and sustainability with a focus on building transformative innovations from seed to later-stage.
Johnson & Johnson Innovation
A global pharmaceutical and medical device leader that partners with early-stage businesses to develop transformational healthcare solutions through a network of regional innovation centers.
NVentures
An exploration firm providing technical and commercial intelligence, now expanding its strategic interest into the high-growth medical technology and innovation sector.
What's next for Moon Surgical?
With the recent infusion of capital, Moon Surgical is poised to transition from its current growth phase into a broader commercial expansion. The strategic focus will likely center on scaling the Maestro System's footprint across international healthcare markets and deepening the analytical capabilities of its software suite. As the company continues to refine its robotic assistance technology, it remains focused on fostering collaborative partnerships with global medical institutions. This roadmap suggests a commitment to long-term value creation, ensuring that the firm remains at the forefront of the digital surgery revolution while maintaining its mission to advance the art of surgical intervention through technological excellence.
See full Moon Surgical company page
